L-Carnosine
(Synonyms: 肌肽; L-肌肽) 目录号 : GC30465A dipeptide with diverse biological activities
Cas No.:305-84-0
Sample solution is provided at 25 µL, 10mM.
L-Carnosine is a dipeptide composed of β-alanine and L-histidine that has been found in rat olfactory bulb, skeletal muscle, brain, kidney, and spleen tissues, as well as human skeletal muscle, and has diverse biological activities.1 It is a metal chelator that forms complexes with copper, cobalt, nickel, cadmium, or zinc. Dietary administration of L-carnosine (60 mg/kg per day) reduces plasma levels of advanced glycation end products (AGEs) in diabetic rats.2 It reduces brain edema, blood-brain barrier disruption, microglial activation, and neuronal apoptosis in a rat model of intracerebral hemorrhage when administered at a dose of 1,000 mg/kg.3 L-Carnosine (250, 500, and 1,000 mg/kg, i.p.) reduces hepatic protein carbonylation and necrosis in a rat model of cirrhosis induced by bile duct ligation.4 It also reduces lung myeloperoxidase (MPO) activity, production of reactive oxygen species (ROS), and TNF-α and IL-6 levels, as well as alveolar hemorrhage, interstitial edema, and pulmonary leukocyte infiltration in a mouse model of LPS-induced lung injury.5
1.Boldyrev, A.A., Aldini, G., and Derave, W.Physiology and pathophysiology of carnosinePhysiol. Rev.93(4)1803-1845(2013) 2.Ghodsi, R., and Kheirouri, S.Carnosine and advanced glycation end products: A systematic reviewAmino Acids50(9)1177-1186(2018) 3.Xie, R.-x., Li, D.-w., Liu, X.-c., et al.Carnosine attenuates brain oxidative stress and apoptosis after intracerebral hemorrhage in ratsNeurochem. Res.42(2)541-551(2017) 4.Jamshidzadeh, A., Heidari, R., Latifpour, Z., et al.Carnosine ameliorates liver fibrosis and hyperammonemia in cirrhotic ratsClin. Res. Hepatol. Gastroenterol.41(4)424-434(2017) 5.Tanaka, K.I., Sugizaki, T., Kanada, Y., et al.Preventive effects of carnosine on lipopolysaccharide-induced lung injurySci. Rep.7:42813(2017)
Cas No. | 305-84-0 | SDF | |
别名 | 肌肽; L-肌肽 | ||
Canonical SMILES | OC([C@@H](NC(CCN)=O)CC1=CN=CN1)=O | ||
分子式 | C9H14N4O3 | 分子量 | 226.23 |
溶解度 | Water: 125 mg/mL (552.54 mM) | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 4.4203 mL | 22.1014 mL | 44.2028 mL |
5 mM | 0.8841 mL | 4.4203 mL | 8.8406 mL |
10 mM | 0.442 mL | 2.2101 mL | 4.4203 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet